A detailed history of Black Rock Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,337,672 shares of VERA stock, worth $142 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,337,672
Previous 3,318,964 0.56%
Holding current value
$142 Million
Previous $143 Million 15.62%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$33.72 - $48.82 $630,833 - $913,324
18,708 Added 0.56%
3,337,672 $121 Million
Q1 2024

May 10, 2024

BUY
$14.91 - $49.14 $8.41 Million - $27.7 Million
564,070 Added 20.48%
3,318,964 $143 Million
Q4 2023

Feb 13, 2024

BUY
$9.29 - $16.0 $3.68 Million - $6.34 Million
396,476 Added 16.81%
2,754,894 $42.4 Million
Q3 2023

Nov 13, 2023

BUY
$13.71 - $19.64 $2.58 Million - $3.7 Million
188,284 Added 8.68%
2,358,418 $32.3 Million
Q2 2023

Aug 11, 2023

BUY
$6.11 - $17.83 $4.64 Million - $13.5 Million
759,864 Added 53.88%
2,170,134 $34.8 Million
Q1 2023

May 12, 2023

BUY
$5.41 - $18.3 $2.89 Million - $9.78 Million
534,386 Added 61.01%
1,410,270 $10.9 Million
Q4 2022

Feb 13, 2023

BUY
$15.74 - $22.19 $1.34 Million - $1.89 Million
85,089 Added 10.76%
875,884 $16.9 Million
Q3 2022

Nov 14, 2022

BUY
$13.27 - $22.31 $978,808 - $1.65 Million
73,761 Added 10.29%
790,795 $16.9 Million
Q2 2022

Aug 12, 2022

BUY
$12.82 - $23.4 $478,942 - $874,200
37,359 Added 5.5%
717,034 $9.76 Million
Q1 2022

May 12, 2022

BUY
$17.8 - $28.06 $4 Million - $6.3 Million
224,575 Added 49.35%
679,675 $16 Million
Q4 2021

Feb 10, 2022

BUY
$15.01 - $35.8 $2.12 Million - $5.05 Million
141,063 Added 44.92%
455,100 $12.2 Million
Q3 2021

Nov 09, 2021

BUY
$13.71 - $30.6 $4.3 Million - $9.59 Million
313,444 Added 52857.34%
314,037 $5.45 Million
Q2 2021

Aug 11, 2021

BUY
$11.5 - $19.97 $6,819 - $11,842
593 New
593 $8,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.15B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.